Haemonetics Corp (HAE) New Study Highlights Safety and Efficacy Profile of Haemonetics’ VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures

Haemonetics Corp (NYSE: HAE) FY 2026 Other Release

Newsdesk: